BioCardia, a leader in cardiovascular disease treatment, recently reported its Q4 2025 results, marking a significant ...

Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the year ended December 31, ...

The discovery of a novel approach to promote cardiomyocyte proliferation offers new hope for the treatment of ischemic heart failure. Researchers in the Michael E. DeBakey Department of Surgery at ...

Ischemic heart disease affects more than 18 million Americans, making it the leading cause of death nationwide. This condition occurs when coronary arteries become narrowed or blocked, restricting ...

Ischemic heart disease, the leading cause of death in the United States, has long puzzled researchers. While high serum cholesterol levels are linked to cardiovascular risk, the role of dietary fat ...

Congestive heart failure is a chronic heart condition that usually occurs in older people However people with a history of ...

Research into the protective effects of two anti-inflammatory molecules, transforming growth factor-beta1 (TGF 1) and Heligmosomoides polygyrus TGM (HpTGM), following heart attack found that both ...

Japan has cleared two therapies that began with the same lab technique and ended in very different parts of the body. One is ...